Clemente-Postigo, M
WEHI, 32D (32Dcl3), WT, T315I-BcrAbl-transformed 32D, and TCCS cells were maintained in RPMI 1640 medium (Sigma) supplemented with 10% heat-inactivated FBS, 1% Streptomycin/Penicillin, 1 mM sodium pyruvate, and 10 mM HEPES
At PlexusDx, we focus on precision wellness: aligning your metabolic and genetic context with the right treatment pathway, whether that involves insurance, compounded access, or hybrid strategies
Arg Substitution: Lysine at position 34 is replaced by Arginine
Evaluating bempedoic acid for non-alcoholic fatty liver disease: A review of preclinical and clinical research
Final pricing may vary based on your treatment plan and clinical assessment